| Serial Number | 90175249 |
| Word Mark | TERAIMMUNE |
| Filing Date | Friday, September 11, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, February 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 25, 2021 |
| Goods and Services | Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals |
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy |
| Goods and Services | Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy |
| Goods and Services | Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; scientific and medical research consultancy relating to all the aforesaid services |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 20, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 20, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 20, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 20, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BOUNCE MERGER SUB II, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | MALVERN, PA 19355 |
| Party Name | TeraImmune, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Gaithersburg, MD 20878 |
| Party Name | TeraImmune, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Gaithersburg, MD 20878 |
| Event Date | Event Description |
| Tuesday, September 15, 2020 | NEW APPLICATION ENTERED |
| Tuesday, October 20, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 21, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 29, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, January 29, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, January 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 16, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 16, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, April 18, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 5, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 25, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 25, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 20, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 13, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 13, 2022 | SOU EXTENSION 1 FILED |
| Thursday, January 13, 2022 | SOU EXTENSION 1 GRANTED |
| Saturday, January 15, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 15, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, April 15, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, April 15, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, July 14, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 14, 2022 | SOU EXTENSION 2 FILED |
| Thursday, July 14, 2022 | SOU EXTENSION 2 GRANTED |
| Saturday, July 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 21, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 21, 2022 | SOU EXTENSION 3 FILED |
| Wednesday, December 21, 2022 | SOU EXTENSION 3 GRANTED |
| Friday, December 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 20, 2023 | SOU EXTENSION 4 FILED |
| Thursday, July 20, 2023 | SOU EXTENSION 4 GRANTED |
| Saturday, July 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 26, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, October 5, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, October 5, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, October 5, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, October 5, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 5, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 5, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, February 26, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, February 26, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |